| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.0M | +23.1% |
| R&D Expense | $2.3M | — |
| SG&A Expense | $3.9M | +704.4% |
| Operating Income | $1.4M | -76.9% |
| Income Tax | $0 | — |
| Net Income | $1.8M | +124.3% |
| EPS (Basic) | $0.04 | — |
| EPS (Diluted) | $0.03 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | — |
| Accounts Receivable | $6.0M | +15.7% |
| Current Assets | $12.3M | +89.2% |
| Total Assets | $25.0M | +285.2% |
| Current Liabilities | $4.8M | +17.1% |
| Total Liabilities | $6.8M | +65.7% |
| Stockholders' Equity | $18.2M | +660.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.0M | — |
| Capital Expenditures | $970K | — |
| Investing Cash Flow | -$823K | — |
| Financing Cash Flow | -$1.1M | — |
| Free Cash Flow | $993K | — |